Haoxi Health Technology Ltd Dossier - Source-backed chat

Haoxi Health Technology Ltd

HAONASDAQ

SectorCommunication Services

IndustryAdvertising

Beta (adjusted)-0.38

Intrinsic Value

Insufficient data for a value estimateNot enough reliable inputs to publish a fair value for this company yet.

Market Price $2.70Price as of 1 Oct 2026

Data confidenceNot applicable

Market Cap $988.5K

Enterprise Value −$7M

Shares Outstanding 350.2K diluted

Moat Rating None

Next Earnings Date31 Oct 2026

All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference.

Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted

Thesis Summary

Haoxi Health Technology Ltd (HAO) is experiencing severe financial distress characterized by rapid cash burn, massive credit loss allowances, and significant dilution from continuous capital raises. Despite a 41% year-over-year increase in net revenue to $33.83 million for the six months ended December 31, 2025, the company's net loss widened dramatically to $6.88 million due to a $6.02 million allowance for credit losses on prepaid advertising and third-party loans. To stay afloat, the company has resorted to highly dilutive registered direct offerings and multiple reverse stock splits (including a 1-for-128 split in May 2026). Given the weak corporate governance, high credit risks, and persistent operational cash outflows, we recommend a Sell.

This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.

Our research · scenarios, merits, risks, and invalidation triggersResearch as of 20 Jun 2026

Scenarios · 12-month scenario targetsAnchored at research date

Bear CaseDownside scenario

$0.0525%

Further credit write-offs on advances and loans occur, completely wiping out shareholders' equity. The company fails to maintain Nasdaq listing requirements despite the recent reverse split, leading to delisting or transition to OTC markets.

Base CaseCentral scenario

$0.5070%

The company continues to grow its top-line domestic healthcare marketing services but remains unprofitable due to high administrative expenses and credit impairments. Dilution continues as the company relies on equity financing to fund working capital.

Bull CaseUpside scenario

$1.5015%

The company successfully leverages its strategic AI partnership with Gauss Intelligence to automate content generation, significantly reducing operating costs and improving gross margins. Successful expansion into high-margin digital health services drives the company to net profitability.

Scenarios reflect our research view at the research date.

Key Investment Merits

Strong top-line revenue growth of 41% YoY in the domestic healthcare marketing segment.
Strategic pivot away from loss-making overseas operations, which improved gross margins to 4.72%.

Key Investment Risks

Severe credit risk with $6.02 million in allowances for credit losses on prepaid advertising and third-party loans.
High dilution risk from frequent equity offerings, such as the $6.5 million registered direct offering in May 2026.
History of frequent reverse stock splits (1-for-25 in Jan 2025 and 1-for-128 in May 2026) indicating persistent downward pressure on share price.

Thesis Invalidation Triggers

Achieving sustained net profitability and positive operating cash flows.
Successful recovery of outstanding prepaid advertising advances and third-party loans.

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Explore this dossier

ValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework.